ArticleFrontiers in pharmacology2024

Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic cells.

Emily M Esquea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.